Home / Sweden / Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
11 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
May 17, 2016 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
Get the moves on Infant Bacterial Therapeutics AB by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| March 25, 2019 | Squarepoint OPS LLC | 0.00% | |
| February 19, 2019 | Squarepoint OPS LLC | 0.50% | |
| February 18, 2019 | Squarepoint OPS LLC | 0.50% | |
| February 16, 2018 | Guevoura Fund | 0.00% | |
| January 30, 2018 | Susquehanna International Holding LLC | 0.00% | |
| January 26, 2018 | Guevoura Fund | 0.77% | |
| January 25, 2018 | Guevoura Fund | 0.77% | |
| May 20, 2016 | Susquehanna International Holdings LLC | 1.38% | |
| May 19, 2016 | Susquehanna International Holdings LLC | 0.99% | |
| May 18, 2016 | Susquehanna International Holdings LLC | 0.64% | |
| May 17, 2016 | Susquehanna International Holdings LLC | 0.64% |
Download 11 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 11.99% of the capital sold short
- Elekta AB (publ) 8.91% of the capital sold short
- JM AB 7.61% of the capital sold short
- Bonesupport Holding AB 6.69% of the capital sold short
- Truecaller AB 6.64% of the capital sold short
- Hemnet Group AB (publ) 6.13% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.41% of the capital sold short
- Dynavox Group AB 4.58% of the capital sold short
- RaySearch Laboratories AB (publ) 4.36% of the capital sold short
- Aktiebolaget Electrolux 4.32% of the capital sold short
- AAK AB (publ) 4.23% of the capital sold short
- Tobii AB 3.54% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Infant Bacterial Therapeutics AB, source Finansinspektionen, data as at March 25, 2019, https://www.quivad.com/action/infant-bacterial-therapeutics-ab